BACKGROUND
Dermopigmentation is currently one of the most frequently performed invasive cosmetic procedures. Traumatization of the trigeminal nerve fibers during the process of dermopigmentation can contribute to the recurrence of herpes simplex virus type 1 (HSV-1) and affect the healing process, aesthetic result, increase the risk of HSV-1 transmission to healthy people. The majority of specialists in the field of permanent tattoo do not have medical education, are not aware of the mechanisms of virus reactivation and optimal measures for the prevention of virus transmission, that determines the study’s relevance.
OBJECTIVE
To reveal the reactivation rate of herpes labialis after lip dermopigmentation, to evaluate the effectiveness of preventive medication of antiherpetic drugs before the procedure, to provide protocol for prevention of HSV-1 recurrences.
MATERIAL AND METHODS
A questionnaire survey of 206 respondents, retrospective study of medical history and clinical picture for reactivation of HSV-1 in the form of herpes labialis in patients after the procedure of lip dermopigmentation were performed.
RESULTS
The lip dermopigmentation procedure promotes reactivation of HSV-1 in the form of herpes labialis in 39% of patients. Preventive medication of antiviral drugs a few days before the procedure reduces the probability of recurrence. Antiviral prevention has a dose-dependent effect, which is determined by the choice of regimen for preventive medication of drugs and should be based on the prediction of the infection reactivation risk relative to the patient’s medical history. Valacyclovir may be recommended as an agent of choice.
CONCLUSION
The procedure of lip dermopigmentation increases the risk of HSV-1 transmission to healthy people. It is advisable to carry out the prevention by oral antiherpetic drugs to all users of this service, that will reduce the probability of spreading the causative agent of viral infectious pathology.
